Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 15, 2014 - Issue 7-8
Submit an article Journal homepage
622
Views
43
CrossRef citations to date
0
Altmetric
Clinical Trials

NP001 regulation of macrophage activation markers in ALS: A phase I clinical and biomarker study

Robert G. MillerCalifornia Pacific Medical Center, San Francisco
,
Rongzhen ZhangUniversity of California, San Francisco, California
,
Gilbert BlockNeuraltus Pharmaceuticals, Inc. Palo Alto, California
,
Jonathan KatzCalifornia Pacific Medical Center, San Francisco
,
Richard BarohnUniversity of Kansas Medical Center Research Institute, Kansas City
,
Edward KasarskisUniversity of Kentucky ALS Center, Kentucky Neuroscience Institute, Lexington, USA
,
Dallas ForshewCalifornia Pacific Medical Center, San Francisco
,
Vidhya GopalakrishnanNeuraltus Pharmaceuticals, Inc. Palo Alto, California
&
Michael S. McGrathUniversity of California, San Francisco, California;Neuraltus Pharmaceuticals, Inc. Palo Alto, CaliforniaCorrespondence[email protected]
 show all
Pages 601-609 | Received 15 Apr 2014, Accepted 01 Aug 2014, Published online: 05 Sep 2014

Citations (43)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Niccolò Tempini & David Teira. (2019) Is the genie out of the bottle? Digital platforms and the future of clinical trials. Economy and Society 48:1, pages 77-106.
Read now
Ana Martinez, Maria del Valle Palomo Ruiz, Daniel I. Perez & Carmen Gil. (2017) Drugs in clinical development for the treatment of amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 26:4, pages 403-414.
Read now
Verena C Haringer & Summer B Gibson. (2015) Amyotrophic lateral sclerosis: clinical perspectives. Orphan Drugs: Research and Reviews 5, pages 19-31.
Read now

Articles from other publishers (40)

Corneliu Toader, Nicolaie Dobrin, Felix-Mircea Brehar, Constantin Popa, Razvan-Adrian Covache-Busuioc, Luca Andrei Glavan, Horia Petre Costin, Bogdan-Gabriel Bratu, Antonio Daniel Corlatescu, Andrei Adrian Popa & Alexandru Vlad Ciurea. (2023) From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology. International Journal of Molecular Sciences 24:22, pages 16119.
Crossref
Nicholas J. Maragakis, Mamede de Carvalho & Michael D. Weiss. (2023) Therapeutic targeting of ALS pathways: Refocusing an incomplete picture . Annals of Clinical and Translational Neurology 10:11, pages 1948-1971.
Crossref
Ming Li, Mengjie Wang, Yuanjia Wen, Hongfei Zhang, Guang‐Nian Zhao & Qinglei Gao. (2023) Signaling pathways in macrophages: molecular mechanisms and therapeutic targets. MedComm 4:5.
Crossref
Matteo Calafatti, Germana Cocozza, Cristina Limatola & Stefano Garofalo. (2023) Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis. Frontiers in Immunology 14.
Crossref
Michael S. McGrath, Rongzhen Zhang, Paige M. Bracci, Ari Azhir & Bruce D. Forrest. (2023) Regulation of the Innate Immune System as a Therapeutic Approach to Supporting Respiratory Function in ALS. Cells 12:7, pages 1031.
Crossref
Luca Muzio, Alma Ghirelli, Federica Agosta & Gianvito Martino. 2023. Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment. Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment 523 537 .
Zongzhi Jiang, Ziyi Wang, Xiaojing Wei & Xue-Fan Yu. (2022) Inflammatory checkpoints in amyotrophic lateral sclerosis: From biomarkers to therapeutic targets. Frontiers in Immunology 13.
Crossref
Kim A. Staats, David R. Borchelt, Malú Gámez Tansey & James Wymer. (2022) Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis. Molecular Neurodegeneration 17:1.
Crossref
Rongzhen Zhang, Paige M. Bracci, Ari Azhir, Bruce D. Forrest & Michael S. McGrath. (2022) Macrophage-Targeted Sodium Chlorite (NP001) Slows Progression of Amyotrophic Lateral Sclerosis (ALS) through Regulation of Microbial Translocation. Biomedicines 10:11, pages 2907.
Crossref
Robert G. Miller, Rongzhen Zhang, Paige M. Bracci, Ari Azhir, Richard Barohn, Richard Bedlack, Michael Benatar, James D. Berry, Merit Cudkowicz, Edward J. Kasarskis, Hiroshi Mitsumoto, Georgios Manousakis, David Walk, Bjorn Oskarsson, Jeremy Shefner & Michael S. McGrath. (2022) Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre‐specified and post hoc analyses . Muscle & Nerve 66:1, pages 39-49.
Crossref
Hardeep S Malhotra, Balendra P Singh, Neeraj Kumar, Ravindra K Garg, Richard Kirubakaran, Hedley CA Emsley, Suresh Kumar Chhetri, Caroline A Mulvaney & Gemma Villanueva. (2022) Immunomodulatory treatment for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews 2022:7.
Crossref
Francesco Lotti & Serge Przedborski. 2022. Vertebrate Motoneurons. Vertebrate Motoneurons 323 352 .
Elise Liu, Léa Karpf & Delphine Bohl. (2021) Neuroinflammation in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia and the Interest of Induced Pluripotent Stem Cells to Study Immune Cells Interactions With Neurons. Frontiers in Molecular Neuroscience 14.
Crossref
Eleonora Giagnorio, Claudia Malacarne, Renato Mantegazza, Silvia Bonanno & Stefania Marcuzzo. (2021) MyomiRs and their multifaceted regulatory roles in muscle homeostasis and amyotrophic lateral sclerosis. Journal of Cell Science 134:12.
Crossref
Maurits F. J. M. Vissers, Jules A. A. C. Heuberger & Geert Jan Groeneveld. (2021) Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders. International Journal of Molecular Sciences 22:4, pages 1615.
Crossref
Pamela A. McCombe, John D. Lee, Trent M. Woodruff & Robert D. Henderson. (2020) The Peripheral Immune System and Amyotrophic Lateral Sclerosis. Frontiers in Neurology 11.
Crossref
Lucas Vu, Jiyan An, Tina Kovalik, Tania Gendron, Leonard Petrucelli & Robert Bowser. (2020) Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes. Journal of Neurology, Neurosurgery & Psychiatry 91:4, pages 350-358.
Crossref
Tereza Filipi, Zuzana Hermanova, Jana Tureckova, Ondrej Vanatko & Miroslava Anderova. (2020) Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment. Journal of Clinical Medicine 9:1, pages 261.
Crossref
Kyle J. Trageser, Chad Smith, Francis J. Herman, Kenjiro Ono & Giulio Maria Pasinetti. (2019) Mechanisms of Immune Activation by c9orf72-Expansions in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Frontiers in Neuroscience 13.
Crossref
Lian Li, Jie Liu & Hua She. (2019) Targeting Macrophage for the Treatment of Amyotrophic Lateral Sclerosis. CNS & Neurological Disorders - Drug Targets 18:5, pages 366-371.
Crossref
Archana Prasad, Vidhya Bharathi, Vishwanath Sivalingam, Amandeep Girdhar & Basant K. Patel. (2019) Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience 12.
Crossref
Claudia Figueroa-Romero, Kai Guo, Benjamin J. Murdock, Ximena Paez-Colasante, Christine M. Bassis, Kristen A. Mikhail, Kristen D. Raue, Matthew C. Evans, Ghislaine F. Taubman, Andrew J. McDermott, Phillipe D. O'Brien, Masha G. Savelieff, Junguk Hur & Eva L. Feldman. (2019) Temporal evolution of the microbiome, immune system, and epigenome with disease progression in ALS mice. Disease Models & Mechanisms.
Crossref
Marlena Wosiski‐Kuhn, Miles S. Lyon, James Caress & Carol Milligan. (2018) Inflammation, immunity, and amyotrophic lateral sclerosis: II. immune‐modulating therapies. Muscle & Nerve 59:1, pages 23-33.
Crossref
Anne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, Stephen Wørlich Pedersen, Anne Øberg Lauritsen, Kirsten Møller & Peter Garred. (2018) Amyotrophic lateral sclerosis: The complement and inflammatory hypothesis. Molecular Immunology 102, pages 14-25.
Crossref
Sebastiano Giuseppe Crisafulli, Simona Brajkovic, Maria Sara Cipolat Mis, Valeria Parente & Stefania Corti. (2017) Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis. Molecular Neurobiology 55:4, pages 2789-2813.
Crossref
Leila Bond, Kamren Bernhardt, Priyank Madria, Katherine Sorrentino, Hailee Scelsi & Cassie S. Mitchell. (2018) A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy. Frontiers in Neuroscience 12.
Crossref
Paramita Chakrabarty & Jacob I. Ayers. 2018. Gene Therapy in Neurological Disorders. Gene Therapy in Neurological Disorders 229 246 .
Syed I. Khalid, Leonel Ampie, Ryan Kelly, Shafeeq S. Ladha & Christopher Dardis. (2017) Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials. Frontiers in Neurology 8.
Crossref
Jia Liu & Fei Wang. (2017) Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications. Frontiers in Immunology 8.
Crossref
Dmitry Petrov, Colin Mansfield, Alain Moussy & Olivier Hermine. (2017) ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?. Frontiers in Aging Neuroscience 9.
Crossref
Emiliano Trias, Sofia Ibarburu, Romina Barreto-Núñez & Luis Barbeito. (2017) Significance of aberrant glial cell phenotypes in pathophysiology of amyotrophic lateral sclerosis. Neuroscience Letters 636, pages 27-31.
Crossref
Meredith Harrison-Brown, Guo-Jun Liu & Richard Banati. (2016) Checkpoints to the Brain: Directing Myeloid Cell Migration to the Central Nervous System. International Journal of Molecular Sciences 17:12, pages 2030.
Crossref
Nathan P. Staff & Stanley H. Appel. (2016) The immune system continues to knock at the ALS door. Neuromuscular Disorders 26:6, pages 335-336.
Crossref
Fumito Endo, Okiru Komine & Koji Yamanaka. (2016) Neuroinflammation in motor neuron disease. Clinical and Experimental Neuroimmunology 7:2, pages 126-138.
Crossref
Reyk Hillert, Anne Gieseler, Andreas Krusche, Daniel Humme, Hans-Joachim Röwert-Huber, Wolfram Sterry, Peter Walden & Walter Schubert. (2016) Large molecular systems landscape uncovers T cell trapping in human skin cancer. Scientific Reports 6:1.
Crossref
Jonathan S. Katz, Richard J. Barohn, Mazen M. Dimachkie & Hiroshi Mitsumoto. (2015) The Dilemma of the Clinical Trialist in Amyotrophic Lateral Sclerosis. Neurologic Clinics 33:4, pages 937-947.
Crossref
Walter Schubert. (2015) Advances in toponomics drug discovery: Imaging cycler microscopy correctly predicts a therapy method of amyotrophic lateral sclerosis. Cytometry Part A 87:8, pages 696-703.
Crossref
Robert G. MillerGilbert BlockJonathan S. KatzRichard J. BarohnVidhya GopalakrishnanMerit CudkowiczJane R. ZhangMichael S. McGrathElizabeth LudingtonStan H. AppelAri AzhirJonathan Katz, Giovanna Kushner, Cynthia Wong, Maguerite Engel, Dallas Forshew, Robert Osborne, Brooke Schug, Amy Akers, Bruce Brent, Thais Zayas-Bazan, Shelly McCoy, Neelam Goyal, Will Harris, Marie Gonella, Benjamin R. Brooks, Elena Bravver, Mohammed Sanjak, Amber L. Ward, Amir Mehrizi, Mark Belfiore, Cynthia Lary, Joanne Nemeth, Jill Conway, Ryan Bender, Scott Holsten, Jamie Shue, Hiroshi Mitsumoto, Regina Youngman, Nicole Armstrong, Yei-won Lee, Louis H. Weimer, Thomas BrannaganIIIIII, Michio Hirano, Marta Scotto, Kate Dalton, Richard S. Bedlack, Joel Charles Morgenlander, Candace Lee Boyette, Karen L. Grace, Beth McLendon Arvik, Patrick Thomas Hickey, Burton Lasater Scott, Debra Lynn Heydt, Peggy Perry-Trice, Merit Cudkowicz, James Berry, Nazem Atassi, Kevin Boylan, Kathleen Kennelly, Pamela DeSaro, Amelia Johnston, Angela Huser, Paula Fuqua, Kristin Staggs, Lorraine Babcock, Thomas Kryston, Mark A. Ross, E. Peter Bosch, Josephus L. Verheijde, Yvvonne Grover, Amy K. Duffy, Michael S. Lee, Roxanne R. McLaughlin, Danette J. Musil, Jennifer Early, Dana Whiteman, Joyce A. Wisbey, Ericka P. Simpson, Milvia Y. Pleitez, Luis F. LayJrJr, Sharon, L. Halton, Thomas Schwartz, Linda Blanton, Eugene C. Lai, Erik P Pioro, Rebecca Kuenzler, Nicole Berry, Sara Khan, Nabi Chowdhury, Julia Biernot, Kimberly Goslin, Gregory T. Carter, Patrick M. Corkrey, Mary Ann Kovarik, Jeremy M. Shefner, Laura Simionescu, Megan Grosso, Mary Lou Watson, Melissa A. Reale, Anuradha Duleep, Robert Carhart, Katie Markis, Kristina Money, Travis Boevin, Neil Lava, Jonathan D Glass, Meraida Polak, Latoya Shaw, Jane Bordeau, Susan Rogers, Susan Ferguson, Christina Fournier, Crystal Kelly, Tahseen Mozaffar, Annabel K Wang, Gladys Ramsey, Patricia A Tully, Michael Graves, Martina Wiedau-Pazos, Rebecca Alvarez, Richard Barohn, April L. McVey, Mazen M. Dimachkie, Mamatha Pasnoor, Laura Herbelin, Maureen Walsh, Edward J. Kasarskis, William F. Dotson, Stephen C. Sitzlar, Tammy Tandy, Jeffery Carrico, Susan Phillips, Linda Rice, Kathryn M. Holbrook, David Eckmann, Lisa Chamblin, Janet Townsend, Janet Kaenzig, Lisa Hanley-Borgia, Kathryn E. Vanderpool, Deborah G. Taylor, Jessica Carpenter, Samantha Thomas, Jan Hutchinson & Jason T. King. (2015) Randomized phase 2 trial of NP001, a novel immune regulator. Neurology Neuroimmunology & Neuroinflammation 2:3.
Crossref
Kristopher G. Hooten, David R. Beers, Weihua Zhao & Stanley H. Appel. (2015) Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis. Neurotherapeutics 12:2, pages 364-375.
Crossref
Nam-Hee KimMin Oh Lee. (2015) Update of Therapeutic Clinical Trials for Amyotrophic Lateral Sclerosis. Korean Journal of Clinical Neurophysiology 17:1, pages 1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.